• By ICR Secretariat
  • Posted Tuesday, November 1, 2022

Pfizer planning steep price hike for COVID-19 vaccine


Pfizer is considering hiking the price of its COVID-19 vaccine by roughly four times what it currently charges as it prepares for sales in the U.S. to shift from government contracts to the private market.